INSIGHTS ON LIQUID DOSE MANUFACTURING

• Isolated GENiSYS C Fill-Finish System: Available For Quick Delivery

  Accelerate your parenteral drug production with a fully integrated, isolator-based fill-finish system. Compact design, rapid delivery, and maximum yield for agile drug development.

• 5 Ways Pre-Filled Syringes Contribute To Better Patient Outcomes

  In our series on pre-filled syringes, we explore five key ways this delivery format is enhancing patient outcomes, not just through the medicine it contains, but through the device design itself.

• Quadrupling Inspection Speed With Automated Visual Inspection (AVI)

  JHS boosted vaccine vial inspection speed 4x with automated visual inspection, improving accuracy, efficiency, and capacity to 20 million vials annually using the Seidenader CS-40.

• Vial Breakage During Lyophilization: Root Causes And Mitigation

  Learn how controlling freezing rates, using specialized vials, and employing optimized stoppering techniques can reduce the risk of vial breakage during lyophilization and ensure high product quality.

• A Direct Path To Annex 1 Compliance With Blow/Fill/Seal Technologies

  9/13/2025

  Learn how Blow/Fill/Seal technology supports contamination control, reduces operator risk, and meets sterility assurance requirements under dynamic conditions with advanced airflow and monitoring.

• Headspace Gas Ingress Methods: A Key Solution For CCIT

  12/23/2024

  Gain insight into the development and validation of headspace methods for various product-container configurations with Dr. Derek Duncan and MSc, Josine Wilmer.

• Ensuring Product Safety And Purity With Mycoplasma And Sterility Testing

  10/7/2024

  Discover how the Applied Biosystems™ MycoSEQ™ Plus system and Applied Biosystems™ SteriSEQ™ Rapid Sterility Testing System can help accelerate your cell therapy manufacturing process.

• From Batch, To Continuous Chemistry, To Continuous Processing

  5/14/2024

  Explore how understanding the transport phenomenon in the boundary layer can allow us to engineer the flow to manage the rate-limiting step and intensify the process.

• Mitigating Early Development Risks With Samsung Biologics DEVELOPICK™ Platform

  6/5/2024

  This presentation addresses the critical need for high-throughput, reliable analytical development strategies to support expedited Investigational New Drug (IND) applications.